Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 1998, p. 1110-1114, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Chromosomally Encoded AmpC-Type
-Lactamase in a
Clinical Isolate of Proteus mirabilis
L.
Bret,1,*
C.
Chanal-Claris,1
D.
Sirot,1
E. B.
Chaibi,2
R.
Labia,2 and
J.
Sirot1
Laboratoire de Bactériologie,
Faculté de Médecine, 63001 Clermont-Ferrand
Cedex,1 and
UMR 175, CNRS-MNHN,
29000 Quimper,2 France
Received 30 July 1997/Returned for modification 30 November
1997/Accepted 8 March 1998
A clinical strain of Proteus mirabilis (CF09) isolated
from urine specimens of a patient displayed resistance to amoxicillin (MIC >4,096 µg/ml), ticarcillin (4,096 µg/ml), cefoxitin (64 µg/ml), cefotaxime (256 µg/ml), and ceftazidime (128 µg/ml) and
required an elevated MIC of aztreonam (4 µg/ml). Clavulanic acid did
not act synergistically with cephalosporins. Two
-lactamases with apparent pIs of 5.6 and 9.0 were identified by isoelectric focusing on
a gel. Substrate and inhibition profiles were characteristic of an
AmpC-type
-lactamase with a pI of 9.0. Amplification by PCR with
primers for ampC genes (Escherichia coli,
Enterobacter cloacae, and Citrobacter freundii)
of a 756-bp DNA fragment from strain CF09 was obtained only with
C. freundii-specific primers. Hybridization results showed
that the ampC gene is only chromosomally located while the
TEM gene is plasmid located. After cloning of the gene,
analysis of the complete nucleotide sequence (1,146 bp) showed that
this ampC gene is close to
blaCMY-2, from which it differs by three point
mutations leading to amino acid substitutions Glu
Gly at position
22, Trp
Arg at position 201, and Ser
Asn at position 343. AmpC
-lactamases derived from that of C. freundii (LAT-1,
LAT-2, BIL-1, and CMY-2) have been found in Klebsiella pneumoniae, E. coli, and Enterobacter
aerogenes and have been reported to be plasmid borne. This is the
first example of a chromosomally encoded AmpC-type
-lactamase
observed in P. mirabilis. We suggest that it be designated
CMY-3.
*
Corresponding author. Mailing address: Laboratoire de
Bactériologie, Faculté de Médecine, 28 Place
Henri-Dunant, 63001 Clermont-Ferrand Cedex, France. Phone: 33 4 73 60 80 18. Fax: 33 4 73 27 74 94. E-mail: Danielle.SIROT{at}U-Clermont1.fr.
Antimicrobial Agents and Chemotherapy, May 1998, p. 1110-1114, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Farber, J., Moder, K.-A., Layer, F., Tammer, I., Konig, W., Konig, B.
(2008). Extended-Spectrum Beta-Lactamase Detection with Different Panels for Automated Susceptibility Testing and with a Chromogenic Medium. J. Clin. Microbiol.
46: 3721-3727
[Abstract]
[Full Text]
-
Empel, J., Baraniak, A., Literacka, E., Mrowka, A., Fiett, J., Sadowy, E., Hryniewicz, W., Gniadkowski, M., and the Beta-PL Study Group,
(2008). Molecular Survey of {beta}-Lactamases Conferring Resistance to Newer {beta}-Lactams in Enterobacteriaceae Isolates from Polish Hospitals. Antimicrob. Agents Chemother.
52: 2449-2454
[Abstract]
[Full Text]
-
Ruppe, E., Bidet, P., Verdet, C., Arlet, G., Bingen, E.
(2006). First Detection of the Ambler Class C 1 AmpC {beta}-Lactamase in Citrobacter freundii by a New, Simple Double-Disk Synergy Test. J. Clin. Microbiol.
44: 4204-4207
[Abstract]
[Full Text]
-
Walther-Rasmussen, J., Hoiby, N.
(2006). OXA-type carbapenemases. J Antimicrob Chemother
57: 373-383
[Abstract]
[Full Text]
-
D'Andrea, M. M., Nucleo, E., Luzzaro, F., Giani, T., Migliavacca, R., Vailati, F., Kroumova, V., Pagani, L., Rossolini, G. M.
(2006). CMY-16, a Novel Acquired AmpC-Type {beta}-Lactamase of the CMY/LAT Lineage in Multifocal Monophyletic Isolates of Proteus mirabilis from Northern Italy. Antimicrob. Agents Chemother.
50: 618-624
[Abstract]
[Full Text]
-
Literacka, E., Empel, J., Baraniak, A., Sadowy, E., Hryniewicz, W., Gniadkowski, M.
(2004). Four Variants of the Citrobacter freundii AmpC-Type Cephalosporinases, Including Novel Enzymes CMY-14 and CMY-15, in a Proteus mirabilis Clone Widespread in Poland. Antimicrob. Agents Chemother.
48: 4136-4143
[Abstract]
[Full Text]
-
Tenover, F. C., Raney, P. M., Williams, P. P., Rasheed, J. K., Biddle, J. W., Oliver, A., Fridkin, S. K., Jevitt, L., McGowan, J. E. Jr.
(2003). Evaluation of the NCCLS Extended-Spectrum {beta}-Lactamase Confirmation Methods for Escherichia coli with Isolates Collected during Project ICARE. J. Clin. Microbiol.
41: 3142-3146
[Abstract]
[Full Text]
-
Mammeri, H., Poirel, L., Mangeney, N., Nordmann, P.
(2003). Chromosomal Integration of a Cephalosporinase Gene from Acinetobacter baumannii into Oligella urethralis as a Source of Acquired Resistance to {beta}-Lactams. Antimicrob. Agents Chemother.
47: 1536-1542
[Abstract]
[Full Text]
-
Decre, D., Verdet, C., Raskine, L., Blanchard, H., Burghoffer, B., Philippon, A., Sanson-Le-Pors, M. J., Petit, J. C., Arlet, G.
(2002). Characterization of CMY-type {beta}-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area. J Antimicrob Chemother
50: 681-688
[Abstract]
[Full Text]
-
Bonnet, R., Marchandin, H., Chanal, C., Sirot, D., Labia, R., De Champs, C., Jumas-Bilak, E., Sirot, J.
(2002). Chromosome-Encoded Class D {beta}-Lactamase OXA-23 in Proteus mirabilis. Antimicrob. Agents Chemother.
46: 2004-2006
[Abstract]
[Full Text]
-
Barlow, M., Hall, B. G.
(2002). Origin and Evolution of the AmpC {beta}-Lactamases of Citrobacter freundii. Antimicrob. Agents Chemother.
46: 1190-1198
[Abstract]
[Full Text]
-
Philippon, A., Arlet, G., Jacoby, G. A.
(2002). Plasmid-Determined AmpC-Type {beta}-Lactamases. Antimicrob. Agents Chemother.
46: 1-11
[Full Text]
-
Navarro, F., Perez-Trallero, E., Marimon, J. M., Aliaga, R., Gomariz, M., Mirelis, B.
(2001). CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother
48: 383-389
[Abstract]
[Full Text]
-
Steward, C. D., Rasheed, J. K., Hubert, S. K., Biddle, J. W., Raney, P. M., Anderson, G. J., Williams, P. P., Brittain, K. L., Oliver, A., McGowan, J. E. Jr., Tenover, F. C.
(2001). Characterization of Clinical Isolates of Klebsiella pneumoniae from 19 Laboratories Using the National Committee for Clinical Laboratory Standards Extended-Spectrum {beta}-Lactamase Detection Methods. J. Clin. Microbiol.
39: 2864-2872
[Abstract]
[Full Text]
-
Chanal, C., Bonnet, R., De Champs, C., Sirot, D., Labia, R., Sirot, J.
(2000). Prevalence of beta -Lactamases among 1,072 Clinical Strains of Proteus mirabilis: a 2-Year Survey in a French Hospital. Antimicrob. Agents Chemother.
44: 1930-1935
[Abstract]
[Full Text]
-
Coudron, P. E., Moland, E. S., Thomson, K. S.
(2000). Occurrence and Detection of AmpC Beta-Lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates at a Veterans Medical Center. J. Clin. Microbiol.
38: 1791-1796
[Abstract]
[Full Text]
-
Bonnet, R., De Champs, C., Sirot, D., Chanal, C., Labia, R., Sirot, J.
(1999). Diversity of TEM Mutants in Proteus mirabilis. Antimicrob. Agents Chemother.
43: 2671-2677
[Abstract]
[Full Text]
-
Stapleton, P. D., Shannon, K. P., French, G. L.
(1999). Carbapenem Resistance in Escherichia coli Associated with Plasmid-Determined CMY-4 beta -Lactamase Production and Loss of an Outer Membrane Protein. Antimicrob. Agents Chemother.
43: 1206-1210
[Abstract]
[Full Text]
-
Trépanier, S., Knox, J. R., Clairoux, N., Sanschagrin, F., Levesque, R. C., Huletsky, A.
(1999). Structure-Function Studies of Ser-289 in the Class C beta -Lactamase from Enterobacter cloacae P99. Antimicrob. Agents Chemother.
43: 543-548
[Abstract]
[Full Text]